VEVIX | VMVAX | VEVIX / VMVAX | |
Total Expense Ratio | 0.58 | 0.07 | 829% |
Annual Report Gross Expense Ratio | 0.58 | 0.07 | 829% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 1.694 | 5.592 | 30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.3B | 31B | 56% |
Annual Yield % from dividends | 1.15 | 2.22 | 52% |
Returns for 1 year | -6.66 | 8.08 | -82% |
Returns for 3 years | -2.06 | 17.95 | -11% |
Returns for 5 years | 35.85 | 65.77 | 55% |
Returns for 10 years | 46.40 | 88.57 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDIV | 39.06 | 0.14 | +0.36% |
SPDR® S&P Emerging Markets Dividend ETF | |||
FCEF | 22.61 | 0.04 | +0.16% |
First Trust Income Opportunity ETF | |||
GDIV | 15.76 | N/A | +0.02% |
Harbor Dividend Growth Leaders ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF | |||
VV | 297.02 | -0.64 | -0.22% |
Vanguard Large-Cap ETF |